Literature DB >> 24498650

A novel mutation of GATA4 (K319E) is responsible for familial atrial septal defect and pulmonary valve stenosis.

Rong Xiang, Liang-Liang Fan, Hao Huang, Bei-Bei Cao, Xiang-Ping Li, Dao-Quan Peng, Kun Xia.   

Abstract

Congenital heart disease (CHD) is the most common birth defect in humans, and the etiology of most CHD remains to be elusive. Atrial septal defect (ASD) makes up 30–40% of all adult CHDs and is thought to be genetically heterogeneous. Previous studies have demonstrated that mutations in transcription factors e.g. NKX2.5, GATA4, and TBX5 contribute to congenital ASD. In this study, we investigate a family of three generations with seven patients with ASD and pulmonary valve stenosis (PS). A novel GATA4 mutation, c.955ANG (p.K319E), was identified and co-segregated with the affected patients in this family. This mutation was predicted to be deleterious by three different bioinformatics programs (The polyphen2, SIFT and MutationTaster). Our finding expands the spectrum of GATA4 mutations and provides additional support that GATA4 plays important roles in cardiac development.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24498650

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  19 in total

1.  Correlation between GATA4 gene polymorphism and congenital heart disease.

Authors:  Xue-Yong Yang; Xiao-Yong Jing; Zhe Chen; Ying-Long Liu
Journal:  Int J Clin Exp Med       Date:  2015-09-15

Review 2.  Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association.

Authors:  Mary Ella Pierpont; Martina Brueckner; Wendy K Chung; Vidu Garg; Ronald V Lacro; Amy L McGuire; Seema Mital; James R Priest; William T Pu; Amy Roberts; Stephanie M Ware; Bruce D Gelb; Mark W Russell
Journal:  Circulation       Date:  2018-11-20       Impact factor: 29.690

3.  Disruption of myocardial Gata4 and Tbx5 results in defects in cardiomyocyte proliferation and atrioventricular septation.

Authors:  Chaitali Misra; Sheng-Wei Chang; Madhumita Basu; Nianyuan Huang; Vidu Garg
Journal:  Hum Mol Genet       Date:  2014-05-08       Impact factor: 6.150

Review 4.  The genetics of isolated congenital heart disease.

Authors:  Shannon N Nees; Wendy K Chung
Journal:  Am J Med Genet C Semin Med Genet       Date:  2019-12-26       Impact factor: 3.908

5.  TBX1 loss-of-function mutation contributes to congenital conotruncal defects.

Authors:  Min Zhang; Fu-Xing Li; Xing-Yuan Liu; Jing-Yi Hou; Shi-Hong Ni; Juan Wang; Cui-Mei Zhao; Wei Zhang; Ye Kong; Ri-Tai Huang; Song Xue; Yi-Qing Yang
Journal:  Exp Ther Med       Date:  2017-10-24       Impact factor: 2.447

6.  Identification of a Novel Arginine Vasopressin Receptor 2 Mutation (p.V183M) in a Chinese Family with Nephrogenic Diabetes Insipidus.

Authors:  Ji-Shi Liu; Hao Huang; Jie-Yuan Jin; Ran Du; Chen-Yu Wang; Liang-Liang Fan
Journal:  Mol Syndromol       Date:  2020-03-28

7.  A novel NKX2.6 mutation associated with congenital ventricular septal defect.

Authors:  Juan Wang; Jian-Hui Mao; Ke-Ke Ding; Wei-Jun Xu; Xing-Yuan Liu; Xing-Biao Qiu; Ruo-Gu Li; Xin-Kai Qu; Ying-Jia Xu; Ri-Tai Huang; Song Xue; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2014-11-08       Impact factor: 1.655

8.  A Novel TBX1 Loss-of-Function Mutation Associated with Congenital Heart Disease.

Authors:  Yun Pan; Zha-Gen Wang; Xing-Yuan Liu; Hong Zhao; Ning Zhou; Gui-Fen Zheng; Xing-Biao Qiu; Ruo-Gu Li; Fang Yuan; Hong-Yu Shi; Xu-Min Hou; Yi-Qing Yang
Journal:  Pediatr Cardiol       Date:  2015-04-10       Impact factor: 1.655

9.  Identification of a novel mutation in the C6 gene of a Han Chinese C6SD child with meningococcal disease.

Authors:  Ai-Qian Zhang; Yu-Xing Liu; Jie-Yuan Jin; Chen-Yu Wang; Liang-Liang Fan; Da-Bao Xu
Journal:  Exp Ther Med       Date:  2021-03-19       Impact factor: 2.447

Review 10.  Genetics of valvular heart disease.

Authors:  Stephanie LaHaye; Joy Lincoln; Vidu Garg
Journal:  Curr Cardiol Rep       Date:  2014       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.